Genome Voyager

Streamline Interpretation and Reporting of Panels, Exomes and Whole Genomes

Medical research tells us that the keys to understanding both disease and good health are hidden inside the three billion base pairs of each human being’s genome. Advances in next generation sequencing (NGS) technology continue to accelerate the rate of discovery and lower the cost of sequencing. Consequently, more institutions are looking to perform sophisticated genetic analysis that can decode an individual’s genetic profile to improve prevention, diagnosis, and treatment of disease.

The Genome Voyager interpretation and reporting platform enables institutions to analyze and interpret sequencing data from targeted gene panels, exomes and whole genomes.  This solution is designed to streamline the interpretation and reporting process so institutions can reduce interpretation time and improve report quality and consistency while continuously expanding their knowledge base.

Join our Beta Program – Now Accepting Applications

The beta program is for institutions that would like to evaluate the Genome Voyager platform and provide feedback for improvements. In exchange for their valuable time and feedback, beta program participants will be provided access to the solution with agreed upon storage limits, free of charge for the duration of the beta program.

Interested in joining the Genome Voyager Beta Program? Click here to submit your application. Please note: space is limited.

During the beta program, access will be offered to accepted participants without any representations or warranties. The Genome Voyager platform has not been evaluated by the U.S. Food and Drug Administration or any other regulatory body for diagnostic use.